T43.622D Poisoning by amphetamines, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by amphetamines, intentional self-harm, subsequent encounter

Summary

This condition describes toxic effects resulting from intentional self-harm involving amphetamines during a subsequent encounter. Amphetamines are central nervous system stimulants, and this code applies to cases where self-directed exposure leads to poisoning, requiring ongoing medical management after the initial episode.

Causes

Intentional self-harm poisoning may result from deliberate ingestion, inhalation, or other routes of amphetamine exposure with the intent to cause harm. This includes misuse of prescription amphetamines (e.g., for ADHD or narcolepsy) or illicit amphetamines. The subsequent encounter indicates follow-up care after the initial event.

Risk Factors

• History of intentional self-harm or suicidal behavior.
• Underlying mental health conditions (e.g., depression, anxiety, or substance use disorders).
• Access to amphetamine medications or illicit substances.
• Previous episodes of poisoning or overdose.

Symptoms

• Persistent agitation, restlessness, or hyperactivity.
• Elevated heart rate, high blood pressure, or palpitations.
• Tremors, muscle rigidity, or seizures.
• Nausea, vomiting, or abdominal pain.
• Hallucinations, paranoia, or other psychiatric disturbances.
• Changes in mental status or mood.

Diagnosis

Diagnosis relies on clinical evaluation, including patient history of intentional self-harm, physical examination, and laboratory tests (e.g., toxicology screening) to confirm amphetamine exposure. Documentation of the self-harm intent and subsequent encounter timing is critical.

Treatment Options

Treatment focuses on managing acute symptoms, preventing complications, and addressing underlying mental health needs. Interventions may include supportive care, medications to stabilize vital signs, and referral to mental health services. Ongoing monitoring is typical during subsequent encounters.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and resolution of underlying mental health issues. Follow-up care often involves continued medical and psychiatric support to reduce recurrence risk. Regular assessments help track recovery and adjust interventions as needed.

Complications

• Cardiovascular issues (e.g., arrhythmias, heart attack).
• Neurological damage (e.g., seizures, coma).
• Psychiatric complications (e.g., prolonged psychosis).
• Organ damage from prolonged toxicity.

Lifestyle & Prevention

• Secure storage of amphetamine medications to prevent access.
• Mental health support and therapy to address self-harm behaviors.
• Education on the risks of amphetamine misuse.
• Avoidance of illicit substances.

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., chest pain, seizures, or altered consciousness). Ongoing professional help is recommended for mental health support and to prevent future episodes.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (subsequent) clearly. Ensure timing aligns with the definition of a subsequent encounter (care after the active treatment phase of the initial episode). Verify amphetamine exposure and self-harm context to support code assignment.